Quality of Life Before and After Transcatheter Ablation in Children With Arrythmias

NCT ID: NCT06808204

Last Updated: 2025-06-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-08-01

Study Completion Date

2027-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to evaluate the improvement in the quality of life after the transcatheter ablation in children from 5 to 17 years old suffering for arrythmia who need a transcatheter ablation (according to PACES recommendations). The main question is:

• to evaluate an improvement in the quality of life in these children, according to different questionnaires?

Participants will answer some questionnaires to get a global evaluation of the quality of life:

* Peds QL 4.0
* Peds QL 4.0 by proxy, which will be completed by the parents
* Ricci and Gagnon questionnaire
* Child Depression Index
* State and Trait Anxiety Inventory

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Arrhythmia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Children from 5 t17 years old suffering for arrythmia who need a transcatheter ablation

Group Type EXPERIMENTAL

Questionnaire

Intervention Type OTHER

Quality of life questionnaire : Peds QL 4.0 (Pediatric Quality of Life )

questionnaire

Intervention Type OTHER

Physical activity level : Ricci and Gagnon questionnaire

questionnaire

Intervention Type OTHER

Anxiety questionnaire : State and Trait Inventory

questionnaire

Intervention Type OTHER

Depression questionnaire : Child Depression Inventory

questionnaire

Intervention Type OTHER

Child Depression Inventory

questionnaire

Intervention Type OTHER

Quality of life of parents before and after transcatheter ablation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaire

Quality of life questionnaire : Peds QL 4.0 (Pediatric Quality of Life )

Intervention Type OTHER

questionnaire

Physical activity level : Ricci and Gagnon questionnaire

Intervention Type OTHER

questionnaire

Anxiety questionnaire : State and Trait Inventory

Intervention Type OTHER

questionnaire

Depression questionnaire : Child Depression Inventory

Intervention Type OTHER

questionnaire

Child Depression Inventory

Intervention Type OTHER

questionnaire

Quality of life of parents before and after transcatheter ablation

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 8 to 17
* Patients with a rhythm disorder,
* Patients with indication for catheter ablation according to PACES (Pediatric and Congenital Electrophysiology Society) recommendations,
* Patients and/or their parents/legal guardians who have given their non-objection to the study.

Exclusion Criteria

* Refusal of child or parents/legal guardians
* Unability to understand and/or fill the quality of life questionnaire
Minimum Eligible Age

5 Years

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospices Civils de Lyon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Francis BESSIERE, Dr

Role: PRINCIPAL_INVESTIGATOR

Hôpital cardiologique Louis Pradel - Hospices Civils de Lyon Service Rythmologie

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital cardiologique Louis Pradel

Bron, , France

Site Status RECRUITING

Hôpital Marie Lannelongue

Le Plessis-Robinson, , France

Site Status NOT_YET_RECRUITING

Hôpital de la Timone

Marseille, , France

Site Status NOT_YET_RECRUITING

Hôpital Necker Enfants Malades

Paris, , France

Site Status NOT_YET_RECRUITING

Hôpital Cardiologique du Haut Lévêque - Service de cardiologie-électrophysiologie et stimulation cardiaque

Pessac, , France

Site Status NOT_YET_RECRUITING

Hôpital Cardiologique du Haut Lévêque - Service des maladies cardio-vasculaires congénitales

Pessac, , France

Site Status NOT_YET_RECRUITING

Clinique Pasteur

Toulouse, , France

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Francis BESSIERE, Dr

Role: CONTACT

04 72 35 75 65 ext. 0033

Nawel BABOURI, CRA

Role: CONTACT

04.26.73.93.83 ext. 0033

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Francis BESSIERE, PhD

Role: primary

0472357565 ext. +33

Alice MALTRET, PhD

Role: primary

01 40 94 25 45 ext. +33

Linda KOUTBI, PhD

Role: primary

04 91 38 65 75 ext. +33

Victor WALDMANN, PhD

Role: primary

01 44 49 43 44 ext. +33

Nicolas DERVAL, PhD

Role: primary

Pascal AMEDRO, PU,PH

Role: primary

Nicolas COMBES, PhD

Role: primary

05 62 21 16 45 ext. +33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-A02568-39

Identifier Type: OTHER

Identifier Source: secondary_id

69HCL24_0830

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.